These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23773058)

  • 21. Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease.
    Papazoglou A; Soos J; Lundt A; Wormuth C; Ginde VR; Müller R; Henseler C; Broich K; Xie K; Ehninger D; Haenisch B; Weiergräber M
    Neural Plast; 2016; 2016():7167358. PubMed ID: 27840743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
    Meunier J; Villard V; Givalois L; Maurice T
    Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.
    Siwek ME; Müller R; Henseler C; Trog A; Lundt A; Wormuth C; Broich K; Ehninger D; Weiergräber M; Papazoglou A
    Neural Plast; 2015; 2015():781731. PubMed ID: 25922768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early increases in soluble amyloid-β levels coincide with cholinergic degeneration in 3xTg-AD mice.
    Girão da Cruz MT; Jordão J; Dasilva KA; Ayala-Grosso CA; Ypsilanti A; Weng YQ; Laferla FM; McLaurin J; Aubert I
    J Alzheimers Dis; 2012; 32(2):267-72. PubMed ID: 22776965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Electrophysiological Disintegration of Hippocampal Neural Networks in a Novel Locus Coeruleus Tau-Seeding Mouse Model of Alzheimer's Disease.
    Ahnaou A; Walsh C; Manyakov NV; Youssef SA; Drinkenburg WH
    Neural Plast; 2019; 2019():6981268. PubMed ID: 31285742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal synaptic activity, pattern separation and episodic-like memory: implications for mouse models of Alzheimer's disease pathology.
    Palmer A; Good M
    Biochem Soc Trans; 2011 Aug; 39(4):902-9. PubMed ID: 21787321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amyloid β protein suppresses hippocampal theta rhythm and induces behavioral disinhibition and spatial memory deficit in rats].
    Yue XH; Liu XJ; Wu MN; Chen JY; Qi JS
    Sheng Li Xue Bao; 2014 Apr; 66(2):97-106. PubMed ID: 24777399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
    Bazzigaluppi P; Beckett TL; Koletar MM; Lai AY; Joo IL; Brown ME; Carlen PL; McLaurin J; Stefanovic B
    J Neurochem; 2018 Mar; 144(5):669-679. PubMed ID: 28777881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Alterations in the Olfactory Neuronal Circuit Occur before Hippocampal Plasticity Deficits in the P301S Mouse Model of Tauopathy: Implications for Early Diagnosis and Translational Research in Alzheimer's Disease.
    Ahnaou A; Rodriguez-Manrique D; Biermans R; Embrechts S; Manyakov NV; Drinkenburg WH
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function.
    Colom LV; Castañeda MT; Bañuelos C; Puras G; García-Hernández A; Hernandez S; Mounsey S; Benavidez J; Lehker C
    Neurobiol Aging; 2010 Jan; 31(1):46-57. PubMed ID: 18547680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease.
    Murphy M; Wilson YM; Vargas E; Munro KM; Smith B; Huang A; Li QX; Xiao J; Masters CL; Reid CA; Barrett GL
    Neurobiol Aging; 2015 Feb; 36(2):740-52. PubMed ID: 25443284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition.
    Mondragón-Rodríguez S; Gu N; Manseau F; Williams S
    Front Cell Neurosci; 2018; 12():121. PubMed ID: 29867356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-amyloid protein (25-35) disrupts hippocampal network activity: role of Fyn-kinase.
    Peña F; Ordaz B; Balleza-Tapia H; Bernal-Pedraza R; Márquez-Ramos A; Carmona-Aparicio L; Giordano M
    Hippocampus; 2010 Jan; 20(1):78-96. PubMed ID: 19294646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain Arrhythmias Induced by Amyloid Beta and Inflammation: Involvement in Alzheimer's Disease and Other Inflammation-related Pathologies.
    Peña-Ortega F
    Curr Alzheimer Res; 2019; 16(12):1108-1131. PubMed ID: 31838994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.